arrow_back Back to App

Long-Term Care Pharmacy Definition: Enhancing Medication Services for Vulnerable Patients

This bill aims to legally define long-term care pharmacies, ensuring individuals with complex health conditions receive specialized medication services. It clarifies the enhanced services these pharmacies must provide, such as 24/7 medication delivery and pharmacist availability, improving the quality and safety of care for those in long-term facilities.
Key points
Establishes a statutory definition for 'long-term care pharmacy' to standardize services.
Mandates enhanced pharmacy and clinical services, including specialized packaging, drug utilization review, and 24/7 access to medication and pharmacists.
Targets individuals with complex chronic conditions residing in care facilities, ensuring they receive tailored medication support.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_5632
Sponsor: Rep. Schrader, Kurt [D-OR-5]
Process start date: 2021-10-19
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Long-Term Care Pharmacy Definition Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_5632.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-10-19.

What are the main provisions?

Key points include:

  • Establishes a statutory definition for 'long-term care pharmacy' to standardize services.
  • Mandates enhanced pharmacy and clinical services, including specialized packaging, drug utilization review, and 24/7 access to medication and pharmacists.
  • Targets individuals with complex chronic conditions residing in care facilities, ensuring they receive tailored medication support.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Schrader, Kurt [D-OR-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health